158 related articles for article (PubMed ID: 29788075)
1. Effects of Immunonutrition in Advanced Human Immunodeficiency Virus Disease: A Randomized Placebo-controlled Clinical Trial (Promaltia Study).
Serrano-Villar S; de Lagarde M; Vázquez-Castellanos J; Vallejo A; Bernadino JI; Madrid N; Matarranz M; Díaz-Santiago A; Gutiérrez C; Cabello A; Villar-García J; Blanco JR; Bisbal O; Sainz T; Moya A; Moreno S; Gosalbes MJ; Estrada V
Clin Infect Dis; 2019 Jan; 68(1):120-130. PubMed ID: 29788075
[TBL] [Abstract][Full Text] [Related]
2. The immunomodulatory nutritional intervention NR100157 reduced CD4+ T-cell decline and immune activation: a 1-year multicenter randomized controlled double-blind trial in HIV-infected persons not receiving antiretroviral therapy (The BITE Study).
Cahn P; Ruxrungtham K; Gazzard B; Diaz RS; Gori A; Kotler DP; Vriesema A; Georgiou NA; Garssen J; Clerici M; Lange JM;
Clin Infect Dis; 2013 Jul; 57(1):139-46. PubMed ID: 23511299
[TBL] [Abstract][Full Text] [Related]
3. Reduced Levels of D-dimer and Changes in Gut Microbiota Composition After Probiotic Intervention in HIV-Infected Individuals on Stable ART.
Stiksrud B; Nowak P; Nwosu FC; Kvale D; Thalme A; Sonnerborg A; Ueland PM; Holm K; Birkeland SE; Dahm AE; Sandset PM; Rudi K; Hov JR; Dyrhol-Riise AM; Trøseid M
J Acquir Immune Defic Syndr; 2015 Dec; 70(4):329-37. PubMed ID: 26258571
[TBL] [Abstract][Full Text] [Related]
4. Effect of 25 weeks probiotic supplementation on immune function of HIV patients.
Hummelen R; Changalucha J; Butamanya NL; Koyama TE; Cook A; Habbema JD; Reid G
Gut Microbes; 2011; 2(2):80-5. PubMed ID: 21637031
[TBL] [Abstract][Full Text] [Related]
5. Effect of a Nutritional Intervention on the Intestinal Microbiota of Vertically HIV-Infected Children: The Pediabiota Study.
Sainz T; Gosalbes MJ; Talavera-Rodríguez A; Jimenez-Hernandez N; Prieto L; Escosa L; Guillén S; Ramos JT; Muñoz-Fernández MÁ; Moya A; Navarro ML; Mellado MJ; Serrano-Villar S
Nutrients; 2020 Jul; 12(7):. PubMed ID: 32708743
[TBL] [Abstract][Full Text] [Related]
6. Probiotic effects on immunity and microbiome in HIV-1 discordant patients.
Blázquez-Bondia C; Parera M; Català-Moll F; Casadellà M; Elizalde-Torrent A; Aguiló M; Espadaler-Mazo J; Santos JR; Paredes R; Noguera-Julian M
Front Immunol; 2022; 13():1066036. PubMed ID: 36569851
[TBL] [Abstract][Full Text] [Related]
7. Effects of hydroxychloroquine on immune activation and disease progression among HIV-infected patients not receiving antiretroviral therapy: a randomized controlled trial.
Paton NI; Goodall RL; Dunn DT; Franzen S; Collaco-Moraes Y; Gazzard BG; Williams IG; Fisher MJ; Winston A; Fox J; Orkin C; Herieka EA; Ainsworth JG; Post FA; Wansbrough-Jones M; Kelleher P;
JAMA; 2012 Jul; 308(4):353-61. PubMed ID: 22820788
[TBL] [Abstract][Full Text] [Related]
8. Effect of Probiotic Supplementation on CD4 Cell Count in HIV-Infected Patients: A Systematic Review and Meta-analysis.
Kazemi A; Djafarian K; Speakman JR; Sabour P; Soltani S; Shab-Bidar S
J Diet Suppl; 2018 Sep; 15(5):776-788. PubMed ID: 29185825
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal effect of CD4 by cotrimoxazole use on malaria incidence among HIV-infected Ugandan adults on antiretroviral therapy: a randomized controlled study.
Kasirye R; Grosskurth H; Munderi P; Levin J; Anywaine Z; Nunn A; Kamali A; Baisley K
Malar J; 2016 Jul; 15():361. PubMed ID: 27417903
[TBL] [Abstract][Full Text] [Related]
10. Effects of HIV, antiretroviral therapy and prebiotics on the active fraction of the gut microbiota.
Deusch S; Serrano-Villar S; Rojo D; Martínez-Martínez M; Bargiela R; Vázquez-Castellanos JF; Sainz T; Barbas C; Moya A; Moreno S; Gosalbes MJ; Estrada V; Seifert J; Ferrer M
AIDS; 2018 Jun; 32(10):1229-1237. PubMed ID: 29683848
[TBL] [Abstract][Full Text] [Related]
11. Safety and immunogenicity of an adjuvanted protein therapeutic HIV-1 vaccine in subjects with HIV-1 infection: a randomised placebo-controlled study.
Harrer T; Plettenberg A; Arastéh K; Van Lunzen J; Fätkenheuer G; Jaeger H; Janssens M; Burny W; Collard A; Roman F; Loeliger A; Koutsoukos M; Bourguignon P; Lavreys L; Voss G
Vaccine; 2014 May; 32(22):2657-65. PubMed ID: 24144472
[TBL] [Abstract][Full Text] [Related]
12. Effects of Prednisolone on Disease Progression in Antiretroviral-Untreated HIV Infection: A 2-Year Randomized, Double-Blind Placebo-Controlled Clinical Trial.
Kasang C; Kalluvya S; Majinge C; Kongola G; Mlewa M; Massawe I; Kabyemera R; Magambo K; Ulmer A; Klinker H; Gschmack E; Horn A; Koutsilieri E; Preiser W; Hofmann D; Hain J; Müller A; Dölken L; Weissbrich B; Rethwilm A; Stich A; Scheller C
PLoS One; 2016; 11(1):e0146678. PubMed ID: 26812052
[TBL] [Abstract][Full Text] [Related]
13. Differential CD4+ cell count increase and CD4+ : CD8+ ratio normalization with maraviroc compared with tenofovir.
Chan ES; Landay AL; Brown TT; Ribaudo HJ; Mirmonsef P; Ofotokun I; Weitzmann MN; Martinson J; Klingman KL; Eron JJ; Fichtenbaum CJ; Plants J; Taiwo BO
AIDS; 2016 Aug; 30(13):2091-7. PubMed ID: 27281061
[TBL] [Abstract][Full Text] [Related]
14. Immune effects of Lactobacillus casei Shirota in treated HIV-infected patients with poor CD4+ T-cell recovery.
Tenore SB; Avelino-Silva VI; Costa PR; Franco LM; Sabino EC; Kalil J; Cerqueira NB; Nakagawa Z; Kallas EG
AIDS; 2020 Mar; 34(3):381-389. PubMed ID: 31714353
[TBL] [Abstract][Full Text] [Related]
15. The benefit of immediate compared with deferred antiretroviral therapy on CD4+ cell count recovery in early HIV infection.
Sharma S; Schlusser KE; de la Torre P; Tambussi G; Draenert R; Pinto AN; Metcalf JA; Neaton JD; Laeyendecker O;
AIDS; 2019 Jul; 33(8):1335-1344. PubMed ID: 31157663
[TBL] [Abstract][Full Text] [Related]
16. A Randomized, Double-blinded, Placebo-controlled Trial of Sitagliptin for Reducing Inflammation and Immune Activation in Treated and Suppressed Human Immunodeficiency Virus Infection.
Dubé MP; Chan ES; Lake JE; Williams B; Kinslow J; Landay A; Coombs RW; Floris-Moore M; Ribaudo HJ; Yarasheski KE
Clin Infect Dis; 2019 Sep; 69(7):1165-1172. PubMed ID: 30535188
[TBL] [Abstract][Full Text] [Related]
17. Safety, immunogenicity and efficacy assessment of HIV immunotherapy in a multi-centre, double-blind, randomised, Placebo-controlled Phase Ib human trial.
Boffito M; Fox J; Bowman C; Fisher M; Orkin C; Wilkins E; Jackson A; Pleguezuelos O; Robinson S; Stoloff GA; Caparrós-Wanderley W
Vaccine; 2013 Nov; 31(48):5680-6. PubMed ID: 24120550
[TBL] [Abstract][Full Text] [Related]
18. The effect of standard dose multivitamin supplementation on disease progression in HIV-infected adults initiating HAART: a randomized double blind placebo-controlled trial in Uganda.
Guwatudde D; Wang M; Ezeamama AE; Bagenda D; Kyeyune R; Wamani H; Manabe YC; Fawzi WW
BMC Infect Dis; 2015 Aug; 15():348. PubMed ID: 26285704
[TBL] [Abstract][Full Text] [Related]
19. Can Probiotics Reduce Inflammation and Enhance Gut Immune Health in People Living with HIV: Study Designs for the Probiotic Visbiome for Inflammation and Translocation (PROOV IT) Pilot Trials.
Kim CJ; Walmsley SL; Raboud JM; Kovacs C; Coburn B; Rousseau R; Reinhard R; Rosenes R; Kaul R
HIV Clin Trials; 2016 Jul; 17(4):147-57. PubMed ID: 27267710
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of Mianyi granules (+mianyi+) for reversal of immune nonresponse following antiretroviral therapy of human immunodeficiency virus-1: a randomized, double-blind, multi-center, placebo-controlled trial.
Ying L; Wen Z; Qingfei X; Xin D; Fuchun Z; Li W; Yonghong LI; Wenhui L; Jian W
J Tradit Chin Med; 2022 Jun; 42(3):432-438. PubMed ID: 35610013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
